CNBC February 27, 2024
Key Points
– Shares of Hims & Hers Health popped Tuesday after the company reported strong fourth-quarter results.
– The company said it expects to deliver its first full year of profitability in 2024.
– CEO Andrew Dudum said specialties such as weight loss, mental health and Hers Dermatology could each deliver more than $100 million in revenue in 2025.
Hims & Hers Health, the online provider of treatments for erectile dysfunction and hair loss, had its best day on the stock market since its debut three years ago after quarterly results beat estimates and the company said it expects to deliver its first full year of profitability in 2024.
Shares of Hims & Hers closed up 31% to $13.43...
Today's Sponsors
Today's Sponsor